Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.39 |
| ▸ | NPY4R | P50391 | 9/20 | 0.39 |
| ▸ | NPY1R | P25929 | 5/20 | 0.39 |
| ▸ | NPY2R | P49146 | 4/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.36 |
| ▸ | OPRL1 | P41146 | 5/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31410869 | 0.95 | NPY4R (0.41) | KEAP1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29531427 | 0.95 | NPY4R (0.41) | KEAP1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29736292 | 0.91 | OPRL1 (0.45) | KEAP1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29987871 | 0.86 | KEAP1 (0.45) | KEAP1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL7996643 | 0.86 | DPP7 (0.42) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29630393 | 0.86 | DPP7 (0.42) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL7996638 | 0.86 | DPP7 (0.42) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29350570 | 0.86 | DPP7 (0.42) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29575475 | 0.84 | MME (0.41) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30063856 | 0.84 | NPY4R (0.46) | NPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |